Current and future approaches to the treatment of immunologic diseases: new targets and new therapeutic agents
The meninges: new therapeutic targets for multiple sclerosis
Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases
Interferon regulatory factors: critical mediators of human lupus
Targeting of type I interferon in systemic autoimmune diseases
Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema
Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases
Bezafibrate, a peroxisome proliferator–activated receptor α agonist, decreases circulating CD14+CD16+ monocytes in patients with type 2 diabetes
Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice
Relationship between sirtuin and mitochondrial uncoupling protein genes and carotid artery stiffness
N-Glycosylation of apolipoprotein A1 in cardiovascular diseases
N-Glycosylation of apolipoprotein A1 in cardiovascular diseases